Cerebral Palsy — Examining the Effect of Eye Gaze Technology on Children With Cortical Visual Impairment
Citation(s)
Ben Itzhak N, Kooiker MJG, van der Steen J, Pel JJM, Wagemans J, Ortibus E The relation between visual orienting functions, daily visual behaviour and visuoperceptual performance in children with (suspected) cerebral visual impairment. Res Dev Disabil. 2021 Dec;119:104092. doi: 10.1016/j.ridd.2021.104092. Epub 2021 Oct 5.
Bennett, C R., Bailin, E. S., Gottlieb, T. K., Bauer, C. M., Bex, P. J., & Merabet, L. B. (2018). Virtual reality based assessment of static object visual search in ocular compared to cerebral visual impairment. In International Conference on Universal Access in Human-Computer Interaction (pp. 28-38). Springer, Cham. https://doi.org/10.1007/978-3-319-92052-8_3
Cemali M, Pekcetin S, Aki E The Effectiveness of Sensory Integration Interventions on Motor and Sensory Functions in Infants with Cortical Vision Impairment and Cerebral Palsy: A Single Blind Randomized Controlled Trial. Children (Basel). 2022 Jul 27;9(8):1123. doi: 10.3390/children9081123.
Chang MY, Borchert MS Advances in the evaluation and management of cortical/cerebral visual impairment in children. Surv Ophthalmol. 2020 Nov-Dec;65(6):708-724. doi: 10.1016/j.survophthal.2020.03.001. Epub 2020 Mar 19.
Chang MY, Borchert MS Methods of visual assessment in children with cortical visual impairment. Curr Opin Neurol. 2021 Feb 1;34(1):89-96. doi: 10.1097/WCO.0000000000000877.
Ferziger, N (2017). Assessment of gaze responses of children with Cerebral Palsy and cerebral visual impairment: Implementation of a computerized video coding system. The American Journal of Occupational Therapy, 71(4_Supplement_1). https://doi.org/10.5014/ajot.2017.71s1-po1138
Gartz, R , Dickerson, A., & Radloff, J. (2019). Effectiveness of visual scanning compensatory training after stroke. The American Journal of Occupational Therapy, 73(4_Supplement_1). https://doi.org/10.5014/ajot.2019.73s1-po2039
Kran BS, Lawrence L, Mayer DL, Heidary G Cerebral/Cortical Visual Impairment: A Need to Reassess Current Definitions of Visual Impairment and Blindness. Semin Pediatr Neurol. 2019 Oct;31:25-29. doi: 10.1016/j.spen.2019.05.005. Epub 2019 May 11.
Manley CE, Bennett CR, Merabet LB Assessing Higher-Order Visual Processing in Cerebral Visual Impairment Using Naturalistic Virtual-Reality-Based Visual Search Tasks. Children (Basel). 2022 Jul 26;9(8):1114. doi: 10.3390/children9081114.
Racey C, Franklin A, Bird CM The processing of color preference in the brain. Neuroimage. 2019 May 1;191:529-536. doi: 10.1016/j.neuroimage.2019.02.041. Epub 2019 Feb 21.
Vancleef K, Janssens E, Petre Y, Wagemans J, Ortibus E Assessment tool for visual perception deficits in cerebral visual impairment: development and normative data of typically developing children. Dev Med Child Neurol. 2020 Jan;62(1):111-117. doi: 10.1111/dmcn.14303. Epub 2019 Jul 2.
VerMaas-Hannan, J , Gehringer, J., Wilson, T., & Kurz, M. (2019). Visual motion perception is aberrant in children with cerebral palsy. The American Journal of Occupational Therapy, 73(4_Supplement_1). https://doi.org/10.5014/ajot.2019.73s1-rp302b
Examining the Effect of Eye Gaze Technology on Children With Cortical Visual Impairment and Its Impact on Occupational Performance
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
